I have come to agree with that last statement you made Seanl as I stated in another post. Big pharma, or big market players will not allow a stock now worth $29M US to accelerate to $2B without a buyout. I hope I'm wrong (I guess), but there is a decent chance of that happening before any pre-efficacy announcement. Why partner when you can just swoop in and buy the farm at this price?
- Forums
- ASX - By Stock
- BLT
- Nasdaq still gives BNTC a strong Buy rating
Nasdaq still gives BNTC a strong Buy rating, page-18
-
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BLT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online